In contrast to hormone-receptor positive breast tumors, TNBCs display aggressive tumor behavior, high proliferation (Ki67), higher risk of relapse and metastatic disease, shorter overall survival, and sensitivity to chemotherapy [1–6]. The gene discussed is MKI67; the disease is breast neoplasm.